US › Healthcare

Beyond Air Inc (XAIR)

US · Healthcare · Medical Devices

$2.16-2.26%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$1.8M

Revenue YoY

+0.5%

Net profit

$-7.9M

EPS

$11.00

EPS estimate

$-8.60

Net margin

-448.8%

EPS came in at 11.00 against a street estimate of -8.60 — a beat of 227.9%.

Key statistics

Market cap

$2.2M

Forward P/E

0.0

P/B

1.48

Book value

$2.69

EPS (TTM)

$-64.40

52-week high

$53.20

52-week low

$2.05

50-day MA

$4.04

200-day MA

$11.69

Beta

0.21

Analyst view

Analysts rate Beyond Air Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $20.00.

Shareholding

Insiders

22.38%

Institutions

7.00%

Largest institutional holders

Fund	Stake
Balyasny Asset Management LLC	2.36%
Murchinson Ltd.	1.39%
Daytona Street Capital LLC	0.77%
Geode Capital Management, LLC	0.57%
Vanguard Capital Management, LLC	0.32%
Vanguard Fiduciary Trust Co	0.15%
BlackRock Inc	0.11%
HRT FINANCIAL LLC	0.11%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Beyond Air Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.